Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The SREBF2 gene encodes sterol regulatory element binding factor 2 (SREBP-2), a transcription factor that regulates cholesterol homeostasis. SREBP-2 activates genes involved in cholesterol uptake and biosynthesis, including HMGCR and LDLR. Dysregulated SREBP-2 signaling has been implicated in Alzheimer's disease through effects on cholesterol metabolism, amyloid precursor protein processing, and neuronal viability.
| SREBF2 | |
|---|---|
| Full Name | Sterol Regulatory Element Binding Transcription Factor 2 |
| Chromosome | 22 |
| Location | 22q13.31 |
| NCBI Gene ID | 6721 |
| OMIM | 184757 |
| Ensembl ID | ENSG00000198911 |
| UniProt ID | Q13568 |
SREBF2 plays a critical role in cholesterol metabolism, which is intimately connected to Alzheimer's disease pathogenesis through multiple mechanisms:
The brain contains approximately 25% of the body's cholesterol but is isolated from peripheral cholesterol by the blood-brain barrier. Key mechanisms include:
| Mechanism | Effect |
|---|---|
| Altered cholesterol metabolism | Increases Aβ production |
| Dysregulated APP processing | Enhances amyloidogenesis |
| Impaired synaptic cholesterol | Defects in neurotransmission |
| Oxidative stress | Neuronal vulnerability |
| Disease | Relationship |
|---|---|
| Hypercholesterolemia | Primary association |
| Alzheimer's Disease | Secondary complication |
| Metabolic Syndrome | Comorbidity |
HMGCR inhibitors (statins) have been studied extensively in AD:
The SREBF2 gene shows distinct expression patterns:
Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.
The study of Srebf2 — Sterol Regulatory Element Binding Transcription Factor 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
Bjorkhem I, et al. (2006). "Cholesterol 24-hydroxylase: an enzyme of cholesterol elimination in the brain." Biochemical and Biophysical Research Communications. DOI:10.1016/j.bbrc.2006.02.114
Carter CJ. (2007). "Alzheimer's disease: APP, gamma-secretase, APOE, LDLR, and cholesterol: a pathological triad?" Journal of Neurochemistry. DOI:10.1111/j.1471-4159.2007.04586.x